Home
Conditions
Nevi and Melanomas

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,362 public trials 405 recruiting studies

Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Recruiting

Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma

NCT04903119

Conditions: BRAF Gene Mutation, Melanoma, Metastatic Melanoma, +11 more
Locations: University of Iowa Iowa City, Iowa, United States

Markey Cancer Center Lexington, Kentucky, United States

St. Luke's University Health Network Easton, Pennsylvania, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Recruiting

Pancreas Registry and High Risk Registry

NCT02775461

Conditions: Chronic Disease, Chronic Pancreatitis, Colonic Diseases, +47 more
Locations: Mount Sinai West New York, United States

Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Recruiting

Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity Using the Vigilant App

NCT06675643

Conditions: Malignant Skin Neoplasm, Melanoma, Neoplasms, +10 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED

NCT06548789

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

A Study of MGC026 in Participants With Advanced Solid Tumors

NCT06242470

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +102 more
Locations: The Angeles Clinic and Research Institute Los Angeles, California, United States

START Midwest Grand Rapids, Michigan, United States

START-New York Long Island Lake Success, New York, United States

Providence Cancer Institute Portland, Oregon, United States

View Trial Details

Recruiting

Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study)

NCT03340129

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +16 more
Locations: Westmead Hospital Sydney, New South Wales, Australia

Calvary Mater NewcastleHospital Waratah, New South Wales, Australia

Melanoma Institute Australia Wollstonecraft, New South Wales, Australia

Princess Alexandra Hospital Woolloongabba, Queensland, Australia

View Trial Details

Recruiting

A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors

NCT07376707

Conditions: Adenocarcinoma, Bronchial Neoplasms, CRC (Colorectal Cancer), +36 more
Locations: Fudan University Shanghai Cancer Center Shanghai, China

View Trial Details

Recruiting

An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors

NCT07371663

Conditions: Ataxia, Ataxia Telangiectasia, Brain Diseases, +60 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Henan Cancer Hospital Zhengzhou, Henan, China

Zhejiang Cancer Hospital Hangzhou, Zhejiang, China

View Trial Details

Recruiting

IMmune checkPoint Inhibitor Related gonAdal toxiCiTy in Premenopausal Women and Men With Melanoma

NCT07138222

Conditions: Inflammation, Melanoma, Melanoma (Skin Cancer), +13 more
Locations: Melanoma Institute Australia Sydney, New South Wales, Australia

Princess Alexandra Hospital Brisbane, Queensland, Australia

Cairns Base Hospital Cairns, Queensland, Australia

Peter MacCallum Cancer Centre Melbourne, Victoria, Australia

View Trial Details

Recruiting

Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi

NCT06599619

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dysplastic Nevus Syndrome, +23 more
Locations: UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Nevi and Melanomas

Nevi and Melanomas trial results

Related conditions